Predictive testing company Signal Genetics Inc. has acquired privately held ChipDX LLC (molecular diagnostics for cancer) for an undisclosed sum. (Feb.)
Included in the acquisition are all of ChipDX’s patents, IP, and knowledge behind a web-based interface for test interpretation by...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?